Harel Insurance Investments & Financial Services Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Pharmaceutical ETF
PPH
|
+$12.8M |
| 2 |
VRNT
Verint Systems
VRNT
|
+$2.67M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.44M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$1.25M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$55.8M |
| 2 |
Nice
NICE
|
+$12.5M |
| 3 |
Vanguard FTSE Pacific ETF
VPL
|
+$8.47M |
| 4 |
EOG Resources
EOG
|
+$4.98M |
| 5 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$2.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.29% |
| 2 | Healthcare | 11.29% |
| 3 | Technology | 5.23% |
| 4 | Energy | 4.56% |
| 5 | Communication Services | 3.65% |
Similar funds
Harel Insurance Investments & Financial Services's Q1 2016 Portfolio in Review
As of Q1 2016, Harel Insurance Investments & Financial Services held 466 positions worth $835M, down 3.2% from $863M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Harel Insurance Investments & Financial Services withdrew a net $83.4M in Q1 2016, closing 93 positions and reducing 104 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $55.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Harel Insurance Investments & Financial Services opened a new position in VanEck Pharmaceutical ETF worth $12.4M.
- Harel Insurance Investments & Financial Services's largest Q1 2016 buy was VanEck Pharmaceutical ETF: 215,790 shares worth $12.4M.
- Harel Insurance Investments & Financial Services added most to Verint Systems in Q1 2016, an estimated $2.67M increase.
- Harel Insurance Investments & Financial Services's biggest Q1 2016 reduction was Vanguard FTSE Pacific ETF, cutting an estimated $8.47M.
- Harel Insurance Investments & Financial Services fully exited Teva Pharmaceuticals in Q1 2016, selling an estimated $55.8M.
- Harel Insurance Investments & Financial Services's ten largest holdings make up 56% of its $835M portfolio in Q1 2016.
- Harel Insurance Investments & Financial Services opened 70 new positions and closed 93 in Q1 2016.
- Harel Insurance Investments & Financial Services's portfolio value fell 3.2% quarter-over-quarter to $835M.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2016, filed 2 May 2016.